CellCept (Genentech, Inc.)
Welcome to the PulseAid listing for the CellCept drug offered from Genentech, Inc.. This Antimetabolite Immunosuppressant [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Genentech, Inc. |
| NON-PROPRIETARY NAME: | Mycophenolate Mofetil |
| SUBSTANCE NAME: | MYCOPHENOLATE MOFETIL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antimetabolite Immunosuppressant [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1995-05-03 |
| END MARKETING DATE: | 0000-00-00 |
CellCept HUMAN PRESCRIPTION DRUG Details:
| Item Description | CellCept from Genentech, Inc. |
| LABELER NAME: | Genentech, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250(mg/1) |
| START MARKETING DATE: | 1995-05-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0004-0259_d5f5de2c-01e5-446e-82be-a1e0e6a3e953 |
| PRODUCT NDC: | 0004-0259 |
| APPLICATION NUMBER: | NDA050722 |
Other MYCOPHENOLATE MOFETIL Pharmaceutical Manufacturers / Labelers:
